Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...

The annual Medicare open enrollment period has arrived, giving millions of Americans the opportunity to review, adjust, or ...

Eli Lilly and Novo Nordisk agree to expand access and cut prices for Zepbound and Wegovy • Medicare to begin covering obesity ...

A deal with drugmakers also means that Medicare would cover obesity drugs for the first time. But certain limitations persist ...

As the new head of the Medicare program, I encourage everyone with Medicare to take full advantage of this year's Open Enrollment period. This is your once-a-year opportunity to take a fresh look at ...

During the open enrollment period, it is extremely important that Medicare beneficiaries review their prescription coverage ...

The deal is with drugmakers Eli Lilly and Novo Nordisk to cut prices of their weight-loss drugs and expand Medicare coverage of these medications.

Millions of middle-aged Americans find themselves in the "sandwich generation," caring for aging parents while managing their ...

This typically forms the backbone of your retirement healthcare coverage, but it's far from perfect. It has six gaping holes that could snare you if you ignore them. Fortunately, the current Medicare ...

Federal health officials are now scrambling to fix tech issues, first reported by The Washington Post, that are displaying ...

Medicare Advantage, also called Part C, is another way to receive your Medicare benefits. These plans, offered by private ...

America's obesity epidemic costs an estimated $173 billion each year. The benefits of covering GLP-1s vastly outweigh the ...